Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 33.9B | 33.8B | 36.4B | 32.4B |
Cost of revenue | 28.4B | 28.3B | 31.0B | 28.2B |
Gross profit | 5.6B | 5.5B | 5.4B | 4.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 2.7B | 2.4B | 3.3B | 2.7B |
Other operating expenses | 904M | 274M | -181M | 199M |
Operating income | 2.7B | 3.1B | 1.8B | 1.7B |
Non operating interest income | ||||
Income | 144M | 131M | 173M | 155M |
Expense | 159M | 143M | 135M | 184M |
Other income expense | — | — | — | — |
Pretax income | 2.6B | 3.1B | 2.1B | 838M |
Tax provision | 772M | 940M | 564M | 362M |
Net income | 1.8B | 2.2B | 1.5B | 476M |
Basic EPS | — | 3.4 | — | 0.6 |
Diluted EPS | — | 3.4 | — | 0.6 |
Basic average shares | — | 620.4M | — | 607.8M |
Diluted average shares | — | 620.4M | — | 607.8M |
EBITDA | 4.9B | 5.4B | 4.4B | 3.1B |
Net income from continuing op. | 2.6B | 3.1B | 2.1B | 838M |
Minority interests | -90M | -76M | -49M | -87M |
Preferred stock dividends | 0 | 0 | 0 | 0 |